State Street’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.6M Sell
3,630,815
-65,664
-2% -$535K ﹤0.01% 1968
2025
Q1
$29M Buy
3,696,479
+702,750
+23% +$5.52M ﹤0.01% 1916
2024
Q4
$44.6M Sell
2,993,729
-17,445
-0.6% -$260K ﹤0.01% 1773
2024
Q3
$46M Sell
3,011,174
-43,882
-1% -$671K ﹤0.01% 1747
2024
Q2
$46.5M Sell
3,055,056
-1,849,457
-38% -$28.2M ﹤0.01% 1717
2024
Q1
$92.6M Buy
4,904,513
+664,936
+16% +$12.6M ﹤0.01% 1362
2023
Q4
$81M Buy
4,239,577
+39,553
+0.9% +$755K ﹤0.01% 1432
2023
Q3
$75.4M Sell
4,200,024
-142,224
-3% -$2.55M ﹤0.01% 1363
2023
Q2
$88.2M Sell
4,342,248
-1,154,005
-21% -$23.4M ﹤0.01% 1309
2023
Q1
$100M Buy
5,496,253
+1,951,970
+55% +$35.6M 0.01% 1187
2022
Q4
$73.3M Sell
3,544,283
-597,777
-14% -$12.4M ﹤0.01% 1382
2022
Q3
$108M Sell
4,142,060
-293,789
-7% -$7.69M 0.01% 1065
2022
Q2
$112M Buy
4,435,849
+1,685,930
+61% +$42.7M 0.01% 1077
2022
Q1
$86.8M Buy
2,749,919
+557,988
+25% +$17.6M ﹤0.01% 1392
2021
Q4
$88.7M Sell
2,191,931
-139,699
-6% -$5.65M ﹤0.01% 1390
2021
Q3
$81.3M Sell
2,331,630
-354,071
-13% -$12.3M ﹤0.01% 1438
2021
Q2
$73.7M Buy
2,685,701
+520,307
+24% +$14.3M ﹤0.01% 1548
2021
Q1
$60.8M Buy
2,165,394
+342,539
+19% +$9.62M ﹤0.01% 1596
2020
Q4
$47.3M Sell
1,822,855
-695,613
-28% -$18.1M ﹤0.01% 1671
2020
Q3
$43.2M Buy
2,518,468
+930,969
+59% +$16M ﹤0.01% 1569
2020
Q2
$39.3M Buy
1,587,499
+943,962
+147% +$23.4M ﹤0.01% 1597
2020
Q1
$8.93M Buy
643,537
+3,070
+0.5% +$42.6K ﹤0.01% 2346
2019
Q4
$6.47M Buy
640,467
+23,221
+4% +$235K ﹤0.01% 2726
2019
Q3
$5.62M Buy
617,246
+6,133
+1% +$55.8K ﹤0.01% 2726
2019
Q2
$4.86M Buy
611,113
+69,738
+13% +$554K ﹤0.01% 2835
2019
Q1
$6.76M Buy
541,375
+31,132
+6% +$389K ﹤0.01% 2619
2018
Q4
$5.5M Buy
510,243
+420,381
+468% +$4.53M ﹤0.01% 2672
2018
Q3
$1.25M Buy
89,862
+25,162
+39% +$351K ﹤0.01% 3368
2018
Q2
$792K Buy
+64,700
New +$792K ﹤0.01% 3424